VICTORIA, June 6 /PRNewswire-FirstCall/ - Aspreva Pharmaceuticals Corporation today announced that Noel Hall, President, will be presenting at the Sixth Annual Needham Biotechnology and Medical Technology Conference in New York.
The 30 minute presentation will be followed by a 30 minute question and answer session. Mr. Hall’s presentation will take place on Wednesday, June 13th at 1:30 pm ET at the New York Palace Hotel.
A live audio webcast of the presentation will be available to all interested parties through a link posted on Aspreva’s website at www.aspreva.com in the Investors section.
About Aspreva Pharmaceuticals
Aspreva is a global pharmaceutical company focused on identifying, developing, and, upon approval, commercializing evidence-based medicines for patients living with less common diseases. Aspreva common stock is traded on the NASDAQ Global Select Market under the trading symbol “ASPV” and on the Toronto Stock Exchange under the trading symbol “ASV”. Learn more at www.aspreva.com.
CONTACT: Sage Baker, VP, Investor Relations & Corporate Communications, Aspreva Pharmaceuticals, (250) 744-2488 ext. 84270, sbaker@aspreva.com
Aspreva Pharmaceuticals
CONTACT: Sage Baker, VP, Investor Relations & Corporate Communications,Aspreva Pharmaceuticals, (250) 744-2488 ext. 84270, sbaker@aspreva.com
